{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "53-year-old woman with a 35 pack-year smoking history developed progressive mid-back pain.",
        "clinical_data": {
          "social_history": [
            {
              "category": "smoking",
              "status": "past",
              "description": "35 pack-year smoking history"
            }
          ],
          "HPI": [
            {
              "summary": "progressive mid-back pain"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Paraspinal mass, multiple bilateral pulmonary nodules, and a dominant 1.7-cm right lower lobe mass were found.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Mass",
              "body_part": "Paraspinal area",
              "modality": "Unknown",
              "finding": "Paraspinal mass",
              "impression": "Paraspinal mass",
              "date": null
            },
            {
              "type": "Nodule",
              "body_part": "Lung",
              "modality": "Unknown",
              "finding": "Multiple bilateral pulmonary nodules",
              "impression": "Multiple bilateral pulmonary nodules",
              "date": null
            },
            {
              "type": "Mass",
              "body_part": "Right lower lobe of lung",
              "modality": "Unknown",
              "finding": "Dominant 1.7-cm right lower lobe mass",
              "impression": "Dominant 1.7-cm right lower lobe mass",
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Biopsy revealed adenocarcinoma consistent with lung primary, harboring a KRAS G12C mutation.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C2350167",
              "label": "Adenocarcinoma of Lung",
              "status": "active"
            }
          ],
          "labs": [
            {
              "test": "KRAS G12C mutation",
              "value": "positive",
              "unit": null,
              "flag": "abnormal"
            }
          ],
          "procedures": [
            {
              "name": "Biopsy",
              "approach": null,
              "date": null,
              "location": "Lung",
              "performed_by": null,
              "outcome": null
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Patient initiated combination ipilimumab 1 mg/kg IV every 6 weeks and nivolumab 3 mg/kg IV every 2 weeks and was transitioned to nivolumab 480 mg IV every 4 weeks as consolidation therapy after 28 months.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0886439",
              "dosage": "1 mg/kg",
              "frequency": "every 6 weeks",
              "modality": "IV",
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C1661229",
              "dosage": "3 mg/kg",
              "frequency": "every 2 weeks",
              "modality": "IV",
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C1661229",
              "dosage": "480 mg",
              "frequency": "every 4 weeks",
              "modality": "IV",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Four months after initiating ipilimumab and nivolumab therapy, the patient developed weakness, fatigue, and orthostatic hypotension.",
        "clinical_data": {
          "HPI": [
            {
              "summary": "Patient developed weakness, fatigue, and orthostatic hypotension four months after initiating ipilimumab and nivolumab therapy.",
              "duration": "4 months",
              "onset": "4 months after initiating ipilimumab and nivolumab therapy",
              "progression": "sudden",
              "associated_symptoms": [
                "weakness",
                "fatigue",
                "orthostatic hypotension"
              ],
              "exacerbating_factors": [
                "ipilimumab",
                "nivolumab"
              ]
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Laboratory assessment revealed low serum concentrations of adrenocorticotropic hormone (<5 pg/mL) and cortisol (0.8 \u03bc/dL).",
        "clinical_data": {
          "labs": [
            {
              "test": "Adrenocorticotropic Hormone Measurement",
              "value": "<5",
              "unit": "pg/mL",
              "flag": "abnormal"
            },
            {
              "test": "Cortisol Measurement",
              "value": "0.8",
              "unit": "\u03bc/dL",
              "flag": "abnormal"
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Patient was diagnosed with hypophysitis featuring secondary adrenal insufficiency and was treated with hydrocortisone.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0020456",
              "label": "Hypophysitis",
              "status": "active"
            },
            {
              "code": "C0235944",
              "label": "Adrenal Insufficiency",
              "status": "active"
            }
          ],
          "medications": [
            {
              "drug": "C0020062",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "C0235944"
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "21 months after hypophysitis diagnosis, the patient experienced a rise in multiple autoantibody levels, including antivitronectin, anti\u2010\u03b22 glycoprotein, antiprothrombin, antiangiotensin receptor 2 type 1, and anti\u2010double-stranded DNA, weeks before the emergence of Raynaud's phenomenon.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0022110",
              "label": "Hypophysitis",
              "status": "historical",
              "onset_date": null
            }
          ],
          "labs": [
            {
              "test": "anti-vitronectin antibody",
              "value": "positive",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "anti-\u03b22 glycoprotein antibody",
              "value": "positive",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "antiprothrombin antibody",
              "value": "positive",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "anti-angiotensin receptor 2 type 1 antibody",
              "value": "positive",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "anti-double-stranded DNA antibody",
              "value": "positive",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            }
          ],
          "HPI": [
            {
              "summary": "Raynaud's phenomenon emerged weeks after a rise in multiple autoantibody levels.",
              "duration": "weeks",
              "onset": null,
              "progression": "sudden",
              "associated_symptoms": [
                "Raynaud's phenomenon"
              ],
              "alleviating_factors": [],
              "exacerbating_factors": []
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Patient's progressive mid-back pain led to imaging."
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Biopsy performed on lung mass.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0005767"
          ],
          "change_type": "addition",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Treatment initiated for adenocarcinoma of the lung.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0886439",
            "C1661229"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Adverse effects developed following immunotherapy.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0043152",
            "C0015672",
            "C0239334"
          ],
          "change_type": "addition",
          "target_domain": "symptom"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Laboratory assessment performed to investigate symptoms.",
        "transition_event": {
          "trigger_type": "lab_change",
          "trigger_entities": [
            "C0001418",
            "C0010198"
          ],
          "change_type": "addition",
          "target_domain": "lab"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Diagnosis and treatment of hypophysitis.",
        "transition_event": {
          "trigger_type": "interpretation",
          "trigger_entities": [
            "C0020456",
            "C0235944"
          ],
          "change_type": "addition",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "Development of autoantibodies and Raynaud's phenomenon.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0034739"
          ],
          "change_type": "addition",
          "target_domain": "symptom"
        }
      }
    }
  ]
}